Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography
Publication Month: Jul 2019 | Report Code: TIPRE00005672 | No. of Pages: 159 | Category: Medical Device | Status: Published
The Cancer Tissue Diagnostics in healthcare market was valued at US$ 2,025.41 million in 2018 and it is projected to reach US$ 3,419.61 million by 2027; it is expected to grow at a CAGR of 6.2% from 2019 to 2027.
Cancer tissue diagnostics techniques are used to detect the tumor in the malignant tissues. In the last few years, immunohistochemistry (IHC) was used to increase the detection of specific antigens in the tumor tissue. The screening with the help of nonfluorescent chromogens is analyzed with conventional microscopy. There are recent techniques developed for cancer tissue diagnosis. Fluorescence in situ hybridization, the method is used for examination of a specific genetic abnormality in the genome. The hybridized deoxyribonucleic acid (DNA) is examined with particular probes. The growth of the Cancer Tissue Diagnostics in healthcare market is attributed to the growing cancer prevalence across the globe, new product launches & FDA approvals and growing investments for tissue diagnostics are boosting the market over the years. In addition, the emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years. However, the growth of the market is restrained by factors such as high cost of cancer diagnostics.
The Cancer Tissue Diagnostics in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Cancer Tissue Diagnostics in Healthcare Market
Get more information on this report :
Market Insights
Growing Applications of Cancer Tissue Diagnostics in Healthcare to Drive Cancer Tissue Diagnostics in Healthcare Market Growth
Cancer is among the leading cause of deaths across the globe and is profoundly affecting the quality of life. Thus, cancer will be a burden on society if not diagnosed and treated on time. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US.
Additionally, cancer is found to be commonly prevalent in European countries as well. As per the Cancer Research UK, in 2016, around 163,444 deaths in the UK were due to cancer.
Furthermore, Asia Pacific region is also facing the problem of the growing prevalence of cancer. The top 15 countries with Cancer prevalence are Japan, Taiwan, Singapore, South Korea, Malaysia, Thailand, China, Philippines, Sri Lanka,
Vietnam, Indonesia, Mongolia, India, Laos, and Cambodia. According to the National Institute of Cancer Prevention and Research (NICPR), in 2018, in India, total deaths due to cancer were 784,821.
These statistics determine an increase in the demand for advanced cancer diagnostics in various regions across the globe. Hence, driving the growth of the cancer tissue diagnostics market during the forecast period.
Frequent FDA approvals and product launches drive the market for cancer tissue diagnostics. Most of the major market players are involved in the manufacturing wide range of cancer diagnostics products that offer maximum advantages and early diagnosis. For instance, in June 2019, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its PD-L1 IHC 22C3 pharmDx assay. The assay is approved to aim in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA (pembrolizumab), antiPD-1 therapy manufactured by Merck.
Furthermore, In March 2018, Agilent Technologies Inc. launched a new color for immunohistochemistry: HRP Magenta for Dako Omnis. The latest staining characteristics of the chromogen will help it for the assessment of skin and lung tissue. Thus, the constant developments in technology in diagnostics along with, FDA approvals accelerate the market growth during the forecast period.
Tissue diagnostics is very crucial in cancer treatment. Cancer tissue diagnostics play a significant role in determining the treatment pace and procedure. Early detection can help in reducing the mortality rates of cancer; hence, medical professionals, market players as well as government authorities implementing new diagnostics and treatment facilities. Thus the rise in investments and better reimbursement policies favor the growth of the cancer tissue diagnostics market.
For instance, in September 2017, OncoStem Diagnostics, invested USD 6 million towards research and development to develop useful tests for brain, colon and oral cancer, and also to automate these tests. Furthermore, Fimmic, which is now, Aiforia Technologies Oy in 2017 invested €5 million to develop, WebMicroscope AI Cloud for tissue diagnostics. Fimmic’s WebMicroscope launched in early 2017, is a tissue diagnostic commercial platform that enables image analysis through deep learning artificial intelligence (AI). In 2019, the company launched AIforia cloud platform, which accelerates image processing and provides automated pathology image analysis. Thus the growing investments for cancer tissue diagnostics have led to the advent of breakthrough techniques, expecting to fuel the growth of the market.
Test Type-Based Insights
In terms of test type, the Cancer Tissue Diagnostics in healthcare market is segmented into immunohistochemical tests and in situ hybridization test. In 2018, the immunohistochemical tests segment held a largest market share 57.65% of the cancer tissue diagnostics market, by product.
Cancer Tissue Diagnostics in Healthcare Market, by Test Type – 2018 and 2027
Get more information on this report :
Strategic Insights
The Cancer Tissue Diagnostics in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Cancer Tissue Diagnostics in Healthcare Market – by Test Type
- Immunohistochemical Tests
o Breast Cancer
o Colorectal Cancer
o Prostate Cancer
o Stomach Cancer
o Others
- In Situ Hybridization Tests
o Breast Cancer
o Lung Cancer
o Bladder Cancer
- o Others
Cancer Tissue Diagnostics in Healthcare Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher Corporation
- Abcam plc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cancer Tissue Diagnostics Market – By Test Type
1.3.2 Global Cancer Tissue Diagnostics Market – By Geography
2. Global Cancer Tissue Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Cancer Tissue Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
5. Global Cancer Tissue Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Growing Cancer Prevalence Across The Globe
5.1.2 New Product Launches & FDA Approvals
5.1.3 Growing Investments For Tissue Diagnostics
5.2 Key Market Restraints
5.2.1 High Cost Of Cancer Diagnostics
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Inclination Towards Personalized Medicine
5.5 Impact Analysis
6. Cancer Tissue Diagnostics Market – Global Analysis
6.1 Global Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
6.2 Global Cancer Tissue Diagnostics Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
7. Global Cancer Tissue Diagnostics Market Analysis– by Test Type
7.1 Overview
7.2 Global Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)
7.3 Immunohistochemical Tests Market
7.3.1 Overview
7.3.2 Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Breast Cancer Market
7.3.3.1 Overview
7.3.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Colorectal Cancer Market
7.3.4.1 Overview
7.3.4.2 Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Prostate Cancer Market
7.3.5.1 Overview
7.3.5.2 Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.6 Stomach Cancer Market
7.3.6.1 Overview
7.3.6.2 Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.7 Others Market
7.3.7.1 Overview
7.3.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 In Situ Hybridization Tests Market
7.4.1 Overview
7.4.2 Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Breast Cancer Market
7.4.3.1 Overview
7.4.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Lung Cancer Market
7.4.4.1 Overview
7.4.4.2 Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.5 Bladder Cancer Market
7.4.5.1 Overview
7.4.5.2 Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.6 Others Market
7.4.6.1 Overview
7.4.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis
8.1 North America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
8.1.1 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.2 North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.1.2.1 North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.2.2 North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.3 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
8.1.4 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.4.1 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.4.2 US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.1.4.2.1 US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.4.2.2 US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.5 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.5.1 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.5.2 Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.1.5.2.1 Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.5.2.2 Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.6 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.6.1 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.6.2 Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.1.6.2.1 Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.6.2.2 Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
8.2.1 Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.2.2.1 Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.2.2 Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.3 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
8.2.4 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.4.1 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.4.2 UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.2.4.2.1 UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.4.2.2 UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.5 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.5.1 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.5.2 Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.2.5.2.1 Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.5.2.2 Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.6 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.6.1 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.6.2 France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.2.6.2.1 France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.6.2.2 France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.7 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.7.1 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.7.2 Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.2.7.2.1 Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.7.2.2 Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.8 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.8.1 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.8.2 Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.2.8.2.1 Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.8.2.2 Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027
8.3.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.2 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.3.2.1 Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2.2 Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
8.3.4 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.4.1 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.4.2 Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.3.4.2.1 Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.4.2.2 Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.5 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.5.1 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.5.2 China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.3.5.2.1 China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.5.2.2 China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.6 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.6.1 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.6.2 India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.3.6.2.1 India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.6.2.2 India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.7 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.7.1 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.7.2 South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.3.7.2.1 South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.7.2.2 South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.8 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.8.1 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.8.2 Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.3.8.2.1 Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.8.2.2 Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
8.4.1 Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.2 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.4.2.1 Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.2.2 Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.3 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
8.4.4 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4.1 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4.2 UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.4.4.2.1 UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.4.2.2 UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.4.3 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4.4 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4.5 Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.4.4.5.1 Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.4.5.2 Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.5 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.5.1 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.5.2 South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.4.5.2.1 South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.5.2.2 South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5 South And Central America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
8.5.1 South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.2 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.5.2.1 South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.2.2 South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.3 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
8.5.4 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4.1 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4.2 Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.5.4.2.1 Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.4.2.2 Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.4.3 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4.4 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4.5 Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
8.5.4.5.1 Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.4.5.2 Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9. Cancer Tissue Diagnostics Market – Industry Landscape
9.1 Overview
9.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
9.4.1 Product Launches
9.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market
9.4.2 Product Approvals
9.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market
9.4.3 Expansion & Other Activities
9.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
9.4.4 Product Enhancements
9.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
9.5 Inorganic Growth Strategies
9.5.1 Overview
9.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
9.6.1 Agreements
9.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market
9.6.2 Partnerships & Collaborations
9.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
9.6.3 Acquisitions
9.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
10. Cancer Tissue Diagnostics Market–Key Company Profiles
10.1 Bio-Rad Laboratories, Inc.
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Information
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Thermo Fisher Scientific, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Abbott
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Enzo Biochem Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Agilent Technologies, Inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Cancer Genetics Inc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Merck Kgaa (Sigma-Aldrich)
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Abcam Plc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Danaher
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Information
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary Of Terms
LIST OF TABLES
Table 1. North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 2. North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 3. North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 4. US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 5. US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 6. US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 7. Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 8. Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 9. Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 10. Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 11. Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 12. Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 13. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 14. Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 15. Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 16. UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 17. UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 18. UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 19. Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 20. Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 21. Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 22. France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 23. France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 24. France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 25. Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 26. Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 27. Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 28. Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 29. Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 30. Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 31. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 32. Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 33. Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 34. Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 35. Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 36. Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 37. China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 38. China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 39. China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 40. India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 41. India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 42. India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 43. South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 44. South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 45. South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 46. Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 47. Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 48. Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 49. Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 50. Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 51. Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 52. UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 53. UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 54. UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 55. Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 56. Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 57. Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 58. South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 59. South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 60. South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 61. South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 62. South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 63. South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 64. Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 65. Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 66. Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 67. Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 68. Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 69. Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 70. Recent Product Launches in the Cancer Tissue Diagnostics Market
Table 71. Recent product Approvals in the Cancer Tissue Diagnostics Market
Table 72. Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
Table 73. Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
Table 74. Recent Agreements By Players In The Cancer Tissue Diagnostics Market
Table 75. Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
Table 76. Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
Table 77. Glossary of Terms, Cancer Tissue Diagnostics Market
LIST OF FIGURES
Figure 1. Cancer Tissue Diagnostics Market Segmentation
Figure 2. Cancer Tissue Diagnostics Segmentation, by Region
Figure 3. Asia Pacific Cancer Tissue Diagnostics Market, Revenue (US$ Mn), By Geography 2018 & 2027
Figure 4. Global Cancer Tissue Diagnostics Market By Test Type, Market Share (%), 2018
Figure 5. North America : PEST Analysis
Figure 6. Europe: PEST Analysis
Figure 7. Asia - Pacific: PEST Analysis
Figure 8. Middle East & Africa: PEST Analysis
Figure 9. South & Central America: PEST Analysis
Figure 10. Most Prevalent Forms of Cancers Globally, 2018
Figure 11. Cancer Tissue Diagnostics Market Impact Analysis of Driver and Restraints
Figure 12. Global Cancer Tissue Diagnostics Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 13. Global Cancer Tissue Diagnostics Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 14. Prominent Players in the Cancer Tissue Diagnostics Market
Figure 15. Global Cancer Tissue Diagnostics Market, by Test Type 2018 & 2027 (%)
Figure 16. Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. North America Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 28. North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
Figure 30. US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Europe Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
Figure 34. Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
Figure 36. UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Asia Pacific Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
Figure 42. Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
Figure 44. Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 48. Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Middle East & Africa Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
Figure 50. Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
Figure 52. UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. South and Central America Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
Figure 56. South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
Figure 58. Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019
Figure 61. Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
Figure 62. Inorganic Developments in the Cancer Tissue Diagnostics Market, 2016-2019(%)
The List of Companies
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Abcam plc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer tissue diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cancer tissue diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
-
$3000
-
$4550 $3640
-
$6550 $5240
-
$8550 $6840
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount